We would like to share ideas on the publication “Long COVID-19 and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): similarities and differences of two peas in a pod.1” Long COVID-19 should be treated as a public health emergency, according to Qanneta. Real prevalence, phenotypes, risk factors, viable therapies, and potential differences with ME/CFS and other overlapping clinical entities must all be determined by well-conducted research.1 We concur that post-COVID issues could occur and that long-term COVID is currently a significant worldwide health issue. From asymptomatic to life-threatening clinical situations, COVID-19 exhibits a broad spectrum of clinical symptoms.2 The main COVID-19 symptom may also be connected to the existence of long-COVID-19. Additionally, not all clinical problems are brought on by COVID-19 recovery. The primary COVID-19 symptom may also be associated to long-COVID-19. Additionally, COVID-19 recovery does not cause all clinical problems. The clinical problems brought on by other medical conditions must be eliminated, even though the current study may give a true impression of prevalence. For instance, even after COVID-19, there remains a risk of developing another severe common disease, such influenza, necessitating the use of preventative measures.3 Therefore, additional medical issues may impede the clinical manifestation. In circumstances where it is practical, a more detailed investigation of the relationships between pre-COVID-19 health data and post-COVID-19 concerns may be possible.